Skip to main content
Clinical Trials/NL-OMON42344
NL-OMON42344RecruitingNot Applicable

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation [CEASE AF - Trial] - CEASE-AF

AtriCure Europe B.V.0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients with Persistent and Longstanding Persistent Atrial Fibrillation
  • Patient is refractory to or intolerant of at least one antiarrhythmic drug (class I or III)

Exclusion Criteria

  • 1. Patient has longstanding persistent AF > 10 years
  • 2. Patient presenting with paroxysmal AF
  • 3. Patient with persistent AF and a LA-diameter <= 4cm
  • 4. AF is secondary to electrolyte imbalance, thyroid disease, or other reversible
  • or non-cardiovascular cause

Investigators

Sponsor
AtriCure Europe B.V.

Similar Trials